Celdara Medical Revenue and Competitors

Lebanon, NH USA

Location

$1.7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Celdara Medical's estimated annual revenue is currently $2.1M per year.(i)
  • Celdara Medical's estimated revenue per employee is $77,500
  • Celdara Medical's total funding is $1.7M.

Employee Data

  • Celdara Medical has 27 Employees.(i)
  • Celdara Medical grew their employee count by -13% last year.

Celdara Medical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Executive Director OperationsReveal Email/Phone
3
Executive Director R&DReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.5M681%N/AN/A
#2
$4.3M284%N/AN/A
#3
$2M138%N/AN/A
#4
$1.1M70%N/AN/A
#5
$3.7M24-11%N/AN/A
#6
$1.1M70%N/AN/A
#7
$45.3M292-9%N/AN/A
#8
$1.4M90%N/AN/A
#9
$2M138%N/AN/A
#10
$7M45-34%N/AN/A
Add Company

What Is Celdara Medical?

Celdara Medical gives hope and health to patients by transforming academic innovations into medicines that cure the world's most challenging diseases. We are a recognized leader with a rich stable of discoveries, developed in concert with premiere research institutions in the US, EU, and beyond. We secure lasting partnerships with inventors and their institutions, and provide the developmental, financial, and business acumen to bridge the gaps between discovery and clinical impact. With robust funding options, operations in greater Boston, Washington DC and New York City, growing affiliates in Seattle and Indianapolis, a wealth of opportunities in our pipeline, and partnerships with industry leaders worldwide, Celdara Medical navigates the path from science to medicine, accelerating innovation to improve human health. Celdara Medical - Transforming innovation into medicine.â„¢

keywords:N/A

$1.7M

Total Funding

27

Number of Employees

$2.1M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.1M284%N/A
#2
$4.3M284%N/A
#3
N/A2856%N/A
#4
$5.7M2822%N/A
#5
$6.5M280%N/A